Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy-Reference-Cited by-同舟云学术

Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy

Published:2020 Issue: Volume:20 Page:e00750
ISSN:2214-2509
Container-title:IDCases
language:en
Short-container-title:IDCases

Author:

Coates Sarah J.,Blasini Amy W.,Musinguzi Patrick,Laker-Oketta Miriam

Funder

National Cancer Institute

Fogarty International Center of the National Institutes of Health

University of California Global Health Institute

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference5 articles.

1. Uganda clinical guidelines 2016;Ministry of Health Uganda,2016

2. Isoniazid induced pellagra despite pyridoxine supplementation;Darvay;Clin Exp Dermatol,1999

3. Pellagra in isoniazid preventive and antiretroviral therapy;Kipsang;IDCases,2019

4. FoodData central;U.S. Department of Agriculture,2019

5. Treatment with isoniazid or rifampin for latent tuberculosis infection: Population-based study of hepatotoxicity, completion, and costs;Ronald;Eur Respir J,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Pellagra—Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease;Cells;2023-02-03

2. Preventing pellagra during isoniazid preventive treatment;The Lancet Global Health;2022-05

3. Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study;The Lancet Global Health;2022-05

4. Pellagra a review exploring causes and mechanisms, including isoniazid‐induced pellagra;Photodermatology, Photoimmunology & Photomedicine;2021-02-02

5. Drugs in tuberculosis and leprosy;Side Effects of Drugs Annual;2021